AGBL1

gene product
CCP4, FLJ32310
Polyglutamylation is a reversible posttranslational modification catalyzed by polyglutamylases that results in the addition of glutamate side chains on the modified protein. This gene encodes a glutamate decarboxylase that catalyzes the deglutamylation of polyglutamylated proteins. Mutations in this gene result in dominant late-onset Fuchs corneal dystrophy. [provided by RefSeq, Nov 2013]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
41 antibodies from 16 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Cusabio Biotech Co., Ltd
1 antibody
Biorbyt
3 antibodies
LifeSpan BioSciences, Inc.
3 antibodies
OriGene
1 antibody
Creative Biolabs
3 antibodies
Abnova Corporation
1 antibody
Invitrogen Antibodies
1 antibody
antibodies-online
6 antibodies
MyBioSource
4 antibodies
Abbexa
1 antibody
United States Biological
12 antibodies
Everest Biotech
1 antibody
Abgent
1 antibody
Creative Diagnostics
1 antibody
Leading Biology
1 antibody
ProSci
1 antibody